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Thienopyridine derivatives have been shown interesting biological activities. New fluorescent 6-
heteroarylthieno[3,2-b]pyridines (Figure 1), recently synthesized by us, have shown interesting inhibitory 
growth activity on three human tumor cell lines, MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell 
lung cancer) and A375-C5 (melanoma) [1].  
In this work, the fluorescence properties of compounds 1-4 were studied in solution and in liposomes of 
different compositions. Compounds 1-4 present very reasonable fluorescence quantum yields in different 
solvents (0.05 ≤ ΦF ≤ 0.50), but are not fluorescent in alcohols and water. 
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Figure 1. Structure of the compounds 1-4.  
 
 
Figure 2. Normalized fluorescence spectra of 3 in 
nanoliposomes.  
 
 
Nanosized liposomes (diameter ≤ 120 nm, measured by DLS) with incorporated compounds were prepared 
using egg yolk phosphatidylcholine (Egg-PC), dipalmitoyl phosphatidylcholine (DPPC), distearoyl 
phosphatidylcholine (DSPC), dipalmitoyl phosphatidylglycerol (DPPG), with or without cholesterol (Ch) 
and distearoyl phosphatidylethanolamine-(PEG)2000 (DSPE-PEG).   
The four compounds exhibit reasonable fluorescence emission when incorporated in liposomes (example of 
compound 3 is presented in Figure 2). Fluorescence anisotropy measurements indicate that compounds 1-4 
can be transported in the hydrophobic region of the lipid bilayer. The liposomal formulation Egg-
PC:Ch:DPPG (7:3:1) is the one with smaller size and lowest polydispersity. These results may be important 
for future drug delivery applications of these potential antitumoral compounds using nanoliposomes as drug 
carriers.  
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